Literature DB >> 8143938

Extracellular ATP in the regulation of renal microvascular function.

E W Inscho1, K D Mitchell, L G Navar.   

Abstract

Considerable attention has been focused on the purine nucleoside, adenosine, in the control of renal blood flow, epithelial transport, and renin secretion; however, surprisingly little attention has been directed toward the renal effects of purine nucleotides such as adenosine triphosphate (ATP). Recent studies utilizing in vivo micropuncture and in vitro techniques have demonstrated that renal vascular, epithelial, and mesangial cells respond to extracellular ATP via mechanisms distinct from those elicited by adenosine. ATP vasoconstricts afferent but not efferent arterioles whereas adenosine vasoconstricts both vascular segments. Adenosine-mediated afferent arteriolar vasoconstriction is abolished by adenosine receptor antagonists, whereas the response to ATP is enhanced. ATP-mediated vasoconstriction reaches a maximum within seconds of exposure while the vasoconstriction induced by adenosine develops more slowly. L-type calcium channel antagonists such as diltiazem or felodipine prevent the sustained afferent vasoconstriction produced by ATP. Data from micropuncture experiments indicate that peritubular capillary infusion of ATP reduces glomerular pressure and results in marked attenuation of the tubuloglomerular feedback mechanism, which transmits signals from the macula densa to the afferent arteriole. These data support the existence of ATP-sensitive P2 purinoceptors in the preglomerular microvasculature that contribute to the control of renal vascular function via activation of calcium channels.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8143938     DOI: 10.1096/fasebj.8.3.8143938

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  9 in total

1.  Extracellular nucleotides activate the p38-stress-activated protein kinase cascade in glomerular mesangial cells.

Authors:  A Huwiler; M Wartmann; H van den Bosch; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  ATP, P2 receptors and the renal microcirculation.

Authors:  Edward W Inscho
Journal:  Purinergic Signal       Date:  2009-03-18       Impact factor: 3.765

Review 3.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

4.  Evidence for two different P2X-receptors mediating vasoconstriction of Ap5A and Ap6A in the isolated perfused rat kidney.

Authors:  M van der Giet; O Cinkilic; J Jankowski; M Tepel; W Zidek; H Schlüter
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 5.  Role of adenosine 5'-triphosphate in regulating renal microvascular function and in hypertension.

Authors:  Zhengrong Guan; Edward W Inscho
Journal:  Hypertension       Date:  2011-07-18       Impact factor: 10.190

Review 6.  Paracrine interactions regulating renal microcirculatory function.

Authors:  L G Navar; E W Inscho; L M Harrison-Bernard; T Takenaka
Journal:  Clin Investig       Date:  1994-09

Review 7.  The dark side of extracellular ATP in kidney diseases.

Authors:  Anna Solini; Vera Usuelli; Paolo Fiorina
Journal:  J Am Soc Nephrol       Date:  2014-12-01       Impact factor: 10.121

8.  Purinergic receptors contribute to early mesangial cell transformation and renal vessel hypertrophy during angiotensin II-induced hypertension.

Authors:  Miguel L Graciano; Akira Nishiyama; Keith Jackson; Dale M Seth; Rudy M Ortiz; Minolfa C Prieto-Carrasquero; Hiroyuki Kobori; L Gabriel Navar
Journal:  Am J Physiol Renal Physiol       Date:  2007-11-07

9.  Vasoconstrictor responses to the P2x-purinoceptor agonist beta, gamma-methylene-L-ATP in human cutaneous and renal blood vessels.

Authors:  I von Kügelgen; B Krumme; U Schaible; P J Schollmeyer; L C Rump
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.